Atlas company financials

SELECTIS HEALTH, INC.

Standardized 12-year financial series for SELECTIS HEALTH, INC., built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.

United StatesCIK 0000727346FY2011 → FY2025

Open JSON Download CSV Download XLSX Quarterly JSON Summary JSON Filing index

Latest fiscal year

FY2025

Revenue

$41.4M

Adjusted EBITDA

—

Net result

-$1M

Net financial debt

$23.3M

Latest source: FY2025 filing · published data snapshot generated April 27, 2026

Phase 2 summary

Latest quarter, TTM, and growth are now pre-computed for chat and templates.

Latest quarter revenue

$10.8M

TTM revenue

$41.8M

TTM free cash flow

—

Latest quarter net result

$752.4K

Quarterly coverage: 34 periods · latest quarter FY2025-Q3 · TTM revenue growth 12.8%.

What this gives you

A proof-of-concept company data surface, not a dead PDF shelf.

The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.

Source audit

Official links first, raw iterFact payloads right next to them.

Official sources

SEC EDGAR companyfacts
primary · selectis-health-inc-fy2011 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2013-02-19 · Retrieved: 2026-04-27T13:23:29.561588+00:00
SEC EDGAR companyfacts
us-gaap:EarningsPerShareBasic · us gaap companyfacts · comparative · selectis-health-inc-fy2011 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2012-10-26 · Retrieved: 2026-04-27T13:23:29.561588+00:00
SEC EDGAR companyfacts
primary · selectis-health-inc-fy2013 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2013-10-15 · Retrieved: 2026-04-27T13:23:29.561588+00:00
SEC EDGAR companyfacts
primary · selectis-health-inc-fy2017 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2019-04-16 · Retrieved: 2026-04-27T13:23:29.561588+00:00
SEC EDGAR companyfacts
us-gaap:InterestExpense · us gaap companyfacts · primary · selectis-health-inc-fy2017 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2018-04-24 · Retrieved: 2026-04-27T13:23:29.561588+00:00

Ten-year series

Headline company financials by fiscal year

Fiscal year	Revenue	Adj. EBITDA	EBIT	Net result	Op. cash flow	Capex	Net debt	Status
FY2011	6M	—	-1M	-1M	301K	-41K	-376K	missing accounts receivable · missing adjusted ebitda · missing cost of revenue · missing gross profit · missing research and development · missing sg and a
FY2012	5M	—	-417K	-809K	-22K	-82K	1M	missing accounts receivable · missing adjusted ebitda · missing cost of revenue · missing gross profit · missing research and development · missing sg and a
FY2013	3M	—	-11K	-2M	40K	-19K	294K	missing accounts receivable · missing adjusted ebitda · missing basic eps · missing cost of revenue · missing diluted eps · missing diluted weighted average shares · missing gross profit · missing research and development · missing sg and a
FY2017	3M	—	465K	-3M	218K	-2M	35M	missing accounts receivable · missing adjusted ebitda · missing cost of revenue · missing current assets · missing current liabilities · missing gross profit · missing inventory · missing research and development · missing sg and a
FY2018	4M	—	475K	-2M	108K	-763K	35M	missing accounts receivable · missing adjusted ebitda · missing cost of revenue · missing current assets · missing current liabilities · missing gross profit · missing inventory · missing research and development · missing sg and a
FY2019	7M	—	1M	-862K	869K	-2M	37M	missing accounts receivable · missing adjusted ebitda · missing cost of revenue · missing current assets · missing current liabilities · missing gross profit · missing inventory · missing research and development · missing sg and a
FY2020	21M	—	3M	3M	3M

Filing provenance